BIO-MANGUINHOS RITUXIMABE 10 MG/ML SOL DIL INFUS CT 1 FR VD TRANS X 50 ML

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1106301570028
  • GGREM 541921110009607
  • Código de barras 7898168491029

O que a fonte publica

Detentor do registro
FUNDACAO OSWALDO CRUZ
Princípios ativos
RITUXIMABE
Embalagem
10 MG/ML SOL DIL INFUS CT 1 FR VD TRANS X 50 ML
Tipo de produto
Biológico
Classe terapêutica
L1G1 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, CD20

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:541921110009607
{
  "name": "BIO-MANGUINHOS RITUXIMABE 10 MG/ML SOL DIL INFUS CT 1 FR VD TRANS X 50 ML",
  "holder": "FUNDACAO OSWALDO CRUZ",
  "stripe": null,
  "barcodes": [
    "7898168491029"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "541921110009607",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": true,
  "holderTaxId": "33.781.055/0001-35",
  "priceRegime": "Regulado",
  "productName": "BIO-MANGUINHOS RITUXIMABE",
  "productType": "Biológico",
  "hospitalOnly": true,
  "presentation": "10 MG/ML SOL DIL INFUS CT 1 FR VD TRANS X 50 ML",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "9561.77",
    "icms-12": "10865.65",
    "icms-17": "11520.20",
    "icms-18": "11660.69",
    "icms-19": "11804.66",
    "icms-20": "11952.21",
    "icms-21": "12103.51",
    "icms-22": "12258.68",
    "icms-23": "12417.88",
    "icms-17.5": "11590.02",
    "icms-19.5": "11877.97",
    "icms-20.5": "12027.39",
    "icms-22.5": "12337.77",
    "icms-12-alc": "9701.48",
    "icms-17-alc": "10285.89",
    "icms-18-alc": "10411.33",
    "icms-19-alc": "10539.86",
    "icms-20-alc": "10671.61",
    "icms-21-alc": "10806.70",
    "icms-22-alc": "10945.24",
    "icms-23-alc": "11087.39",
    "withoutTaxes": "8537.29",
    "icms-17.5-alc": "10348.24",
    "icms-19.5-alc": "10605.33",
    "icms-20.5-alc": "10738.73",
    "icms-22.5-alc": "11015.86"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "RITUXIMABE",
  "targetSpecies": [],
  "consumerPrices": null,
  "invalidBarcodes": [],
  "activeSubstances": [
    "RITUXIMABE"
  ],
  "therapeuticClass": "L1G1 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, CD20",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1106301570028",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "L1G1",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:541921110009607"